Lee-Sepsick Kathy 4

What Happened
Kathy Lee‑Sepsick, CEO of Femasys, was granted 68,244 Series D-1 warrants on March 19, 2026. These are derivative securities (warrants) that give the holder the right to buy common stock at an initial exercise price of $0.58 per share (subject to adjustment). The grant was issued in a private placement as consideration under an Omnibus Amendment and Consent Agreement.

Key Details

• Transaction date: 2026-03-19; Form 4 filed: 2026-03-27 (appears to be filed after the typical 2-business-day Form 4 deadline).
• Security: 68,244 Series D-1 warrants (derivative acquisition, code A).
• Initial exercise price: $0.58 per share (total implied cash needed to exercise all warrants ≈ $39,582), subject to standard adjustments (splits, dividends, recapitalizations).
• Exercise limitations: Holder’s ability to exercise the warrants is subject to Nasdaq Capital Market rules and other warrant terms.
• Issuance reason: Reported as consideration in a private placement tied to an Omnibus Amendment and Consent Agreement dated March 19, 2026.
• Shares owned after transaction: Not specified in the filing.

Context
Warrants are not the same as common stock — they are the right to purchase shares later at a set price. This grant does not immediately increase common‑stock voting power or directly realize cash unless and until the warrants are exercised. The exercise price and Nasdaq limits may restrict timing and economics of any future conversion to common shares.